Cytochrome P450 in cancer susceptibility and treatment

B Mittal, S Tulsyan, S Kumar, RD Mittal… - Advances in clinical …, 2015 - Elsevier
Abstract Cytochrome 450 (CYP450) designates a group of enzymes abundant in smooth
endoplasmic reticulum of hepatocytes and epithelial cells of small intestines. The main …

Glutathione S-Transferase M1 (GSTM1) Polymorphisms and Lung Cancer: A Literature-based Systematic HuGE Review and Meta-Analysis

C Carlsten, GS Sagoo, AJ Frodsham… - American journal of …, 2008 - academic.oup.com
Multiple genes have been studied for potential associations with lung cancer. The gene
most frequently associated with increased risk has been glutathione S-transferase M1 …

Genetic polymorphisms of drug-metabolising enzymes and drug transporters in the chemotherapeutic treatment of cancer

TM Bosch, I Meijerman, JH Beijnen… - Clinical …, 2006 - Springer
There is wide variability in the response of individuals to standard doses of drug therapy.
This is an important problem in clinical practice, where it can lead to therapeutic failures or …

Five glutathione s-transferase gene variants in 23,452 cases of lung cancer and 30,397 controls: meta-analysis of 130 studies

Z Ye, H Song, JPT Higgins, P Pharoah… - PLoS medicine, 2006 - journals.plos.org
Background Glutathione S-transferases (GSTs) are known to abolish or reduce the activities
of intracellular enzymes that help detoxify environmental carcinogens, such as those found …

Meta- and Pooled Analysis of GSTT1 and Lung Cancer: A HuGE-GSEC Review

S Raimondi, V Paracchini, H Autrup… - American journal of …, 2006 - academic.oup.com
Lung cancer is the most common malignancy in the Western world, and the main risk factor
is tobacco smoking. Polymorphisms in metabolic genes may modulate the risk associated …

Distribution of genetic polymorphisms of genes encoding drug metabolizing enzymes & drug transporters-a review with Indian perspective

G Umamaheswaran, DK Kumar… - Indian Journal of Medical …, 2014 - journals.lww.com
Phase I and II drug metabolizing enzymes (DME) and drug transporters are involved in the
absorption, distribution, metabolism as well as elimination of many therapeutic agents …

Possible risk modification by CYP1A1, GSTM1 and GSTT1 gene polymorphisms in lung cancer susceptibility in a South Indian population

L Sreeja, V Syamala, S Hariharan… - Journal of human …, 2005 - nature.com
Susceptibility to lung cancer has been shown to be modulated by inheritance of polymorphic
genes encoding cytochrome P450 1A1 (CYP1A1) and glutathione S transferases (GSTM1 …

Основы клинической иммунометаболомики

АА Савченко, АГ Борисов - 2012 - elibrary.ru
В монографии обобщены современные данные о метаболических механизмах
функционирования клеток иммунной системы при различных иммунопатологических …

Association of xenobiotic metabolizing enzymes genetic polymorphisms with esophageal cancer in Kashmir Valley and influence of environmental factors

MA Malik, R Upadhyay, RD Mittal, SA Zargar… - Nutrition and …, 2010 - Taylor & Francis
The Kashmir Valley has an elevated incidence rate of esophageal cancer (EC). Several
environmental and genetic factors have been suspected for development of EC. A case …

CYP1A1 MspI and exon7 gene polymorphisms and lung cancer risk: an updated meta-analysis and review

P Zhan, Q Wang, Q Qian, SZ Wei, LK Yu - Journal of Experimental & …, 2011 - Springer
Background Many studies have examined the association between the CYP1A1 MspI and
exon 7 gene polymorphisms and lung cancer risk in various populations, but their results …